论文部分内容阅读
WHO(世界卫生组织)全球极端耐药结核(XDR-TB)专题小组会议于2006年10月9～10日在日内瓦召开,会议确认XDR-TB的出现给大众健康造成严重威胁,特别是在与艾滋病毒(HIV)相关联时;专题小组会议还概述了各国为有效防治XDR-TB而必须采取的一系列措施。此外,专题小组将帮助组织工作队,对国家的技术援助要求作出反应并可在短时间内派往XDR-TB的风险地区。会议的召开非常急促,目的是审查目前有关强耐药性结核,包括当与HIV相关联时影响的证据。 WHO代理总干事Anders Nordstr(?)m博士在专题小组会议上强调指出,WHO“坚决承诺”以各种形式支持国家防治结核的努力;采取紧急措施解决XDR-TB的问题至关重要,特别是在HIV高流行地区。与此同时,WHO不应忽视必须长期作出改进以加强结核控制并建设卫生服务的必要能力,以便对耐药性结核作出反应。本次会议在呼吁各国加强结核控制——预防结核抗药性的关键——的同时,就XDR-TB病例的定义达成一致意见。在HIV/艾滋病高度流行的环境下,如果缺乏与结核和HIV规划及干预措施的密切
The World Health Organization (WHO) Task Force on Extremely T-X-TB (XDR-TB) was held in Geneva from October 9 to October 10, 2006. It was recognized that the emergence of XDR-TB poses a serious threat to public health, HIV (HIV); and the panel also outlined a series of measures countries must take to effectively combat XDR-TB. In addition, thematic groups will help organize task forces to respond to national technical assistance requests and to dispatch them to XRT-TB risk areas within a short period of time. The meeting was so steep that the purpose was to review the current evidence on TB drug abuse, including its impact when it is linked to HIV. Dr. Anders Nordsträm, WHO Acting Director-General, emphasized at the panel meeting that WHO’s “strong commitment” is in various ways supporting national efforts to combat TB; it is crucial to take urgent measures to address the issue of XDR-TB, Especially in high HIV prevalence areas. In the meantime, WHO should not overlook the need for long-term improvements to strengthen tuberculosis control and build the health services necessary to respond to drug-resistant TB. The meeting called for countries to strengthen TB control - the key to preventing TB drug resistance - while agreeing on the definition of XDR-TB cases. In the context of HIV / AIDS pandemic, if there is a lack of close ties with tuberculosis and HIV programs and interventions